The markers IFN-γ, IL-13, IFN-γ/IL13, IL-17A/IL-13, IFN-γ/IL4, and IL-17A/IL-4 are representative of predicting the efficacy of psoriasis treatment. This evidence concerns the gene IL17A and psoriasis.